Genentech, Inc.
Clinical trials sponsored by Genentech, Inc., explained in plain language.
-
New drug targets 'Undruggable' cancer mutation in early human trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called GDC-7035 in people with advanced solid tumors that have a specific genetic change called KRAS G12D. The main goals are to find a safe dose and see how the body processes the drug, both when given alone and combined with other ca…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
Healthy volunteers needed for early safety test of experimental drug
Knowledge-focused Recruiting nowThis early-stage study tests an experimental drug called RO7875913 in 40 healthy adults. The main goal is to check for side effects and see how the drug moves through the body. Participants will not receive any treatment for a disease, but the results will help decide safe doses …
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC
-
Healthy volunteers needed to test how food and acid pills change drug absorption
Knowledge-focused Recruiting nowThis study looks at how taking a new medicine (ZN-A-1041) with food or with a common stomach-acid drug (rabeprazole) changes the amount of medicine in the blood. About 48 healthy adults will take the medicine under different conditions to measure absorption. The results will help…
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:03 UTC